Acino, headquartered in Aesch, Switzerland, is a global pharmaceutical company that specializes in developing, manufacturing, and distributing niche prescription, branded over-the-counter (OTC), and generic drugs. The company was founded in 1836 and has since grown to become one of the leading pharmaceutical providers in emerging markets. Acino's extensive product portfolio includes a wide range of therapeutic areas such as pain management, women's health, gastroenterology, and respiratory, among others.

The company's primary focus is on its own brands, but it also collaborates with leading pharmaceutical companies to develop and manufacture their products under licensing agreements. This diversification helps Acino maintain a strong market position and capture a significant share of the global pharmaceutical industry. Operating on a global scale, Acino has a presence in more than 90 countries, with production sites in Switzerland, Germany, Egypt, and Brazil.

The company has established a number of noteworthy partnerships and joint ventures to enhance its global reach. For instance, Acino partnered with Cosmo Pharmaceuticals, a leading specialty pharmaceutical company in Europe, to develop and commercialize innovative gastroenterology products. In terms of market position, Acino is recognized as a key player in emerging markets, particularly in the Middle East, Africa, and Central Asia.

The company's global sales have steadily increased over the years, with a notable presence in Russia, Ukraine, and Mexico. Acino maintains a strong competitive position by offering high-quality products at affordable prices, catering to the specific needs of different markets. Recent achievements include Acino's successful acquisition of PharmaMedica AG in Germany, expanding its manufacturing capabilities and strengthening its foothold in the European market.

The company has also implemented a strategic shift towards digitalization, enabling better patient engagement and improving overall healthcare outcomes. As of the latest update, Acino continues to focus on driving growth through innovation, expanding its product portfolio, and exploring opportunities in new markets. With its dedication to providing affordable and accessible healthcare solutions, Acino remains a trusted and reliable partner in the global pharmaceutical industry